Viewing Study NCT06022250


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-29 @ 8:00 AM
Study NCT ID: NCT06022250
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-18
First Post: 2023-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module